Braxia Scientific Corp.
BRAX
CNSX
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -18.27% | -0.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -18.27% | -0.87% | |||
| Cost of Revenue | -12.98% | -9.12% | |||
| Gross Profit | -37.32% | 47.32% | |||
| SG&A Expenses | 251.96% | -65.15% | |||
| Depreciation & Amortization | -0.73% | 30.86% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 70.42% | -39.31% | |||
| Operating Income | -352.59% | 72.83% | |||
| Income Before Tax | -227.78% | 65.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -227.78% | 65.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -227.78% | 65.94% | |||
| EBIT | -352.59% | 72.83% | |||
| EBITDA | -472.12% | 78.24% | |||
| EPS Basic | -212.50% | 65.22% | |||
| Normalized Basic EPS | -220.00% | 64.29% | |||
| EPS Diluted | -212.50% | 65.22% | |||
| Normalized Diluted EPS | -220.00% | 64.29% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
